Centene Reaffirms Full Year Guidance, Optimistic on Medicare Performance

Centene ( (CNC) ) has provided an update.

On September 10, 2024, Centene Corporation’s senior management will meet with investors to reaffirm their full year adjusted EPS guidance of over $6.80, noting a shift of 20 to 30 cents from Q3 to Q4, with third-quarter adjusted EPS projected between $1.31 and $1.41. They are also optimistic about improvements in their Medicare Advantage stars program performance. The Company emphasizes the use of non-GAAP financial measures for a more consistent evaluation of performance, although these are not meant to replace GAAP measures.

For detailed information about CNC stock, go to TipRanks’ Stock Analysis page.